Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.



Published on

  • 1 Weird Diet Trick Heals Vitiligo Fast ●●●
    Are you sure you want to  Yes  No
    Your message goes here
  • Discover A Simple Holistic System For Curing Acne Once And For All using 100% Guaranteed All-Natural Method. Click Here ★★★
    Are you sure you want to  Yes  No
    Your message goes here


  1. 1. Chris Pearce Dermatology Presentation
  2. 2. Aims To cover: 1. Definition 2.Clinical Presentation 3. Pathology 4.Causative conditions 5.Complications 6.Management 7.Prognosis
  3. 3. Definition Erythroderma , which is also known as Generalised Exfoliative Dermatitis: “An inflammatory dermatosis which involves 90% or more of the skin surface.” (Gawkrodger, 2004)
  4. 4. Clinical Presentation Four key points: 1. Patchy erythema becomes universal over 24-48 hours, accompanied by malaise, shivering and pyrexia. 2. Scaling appears 2-6 day later, when the skin is hot, dry, red and thickened. 3. Skin feels tight and itchy, and patients feel cold. 4. Scalp and body hair is eventually lost, whilst nails become thickened or shed.
  5. 5. Pathology Acute changes – Dermal/epidermal oedema and inflammatory infiltrate. Chronic changes – Lengthened rete ridges and thickened epidermis. Cytokines implicated: IL-1, IL-2, IL-8, ICAM-1, TNFα and IFN-γ (Wilson et al, 1993) Typical changes of underlying lesion.
  6. 6. Causes
  7. 7. Eczema All types of ezcema can become erythrodermic, but this is more common in the elderly (Rothe et al, 2005)
  8. 8. Psoriasis Steroid withdrawal can precipitate erythrodermic psoriasis. Progression can lead to generalised pustular psoriasis. (Kassay et al, 2001) (Gawkrodger, 2004)
  9. 9. Malignancy: Sezary Syndrome (Rothe et al, 2005)(Harrison & Duvic 2004)
  10. 10. Drug reaction Drug reactions of the toxic erythema or mobillform type can become erythrodermic Carbemazepine, phenytoin, diltiazem, cimetidine, gold, allopurinol and sulphonamides are common causes. (Gawkrodger, 2004)
  11. 11. Complications Oedema Lymphadenopathy Minor Major Cardiac failure Metabolic disturbance Hypothermia Cutaneous or respiratory infection
  12. 12. Management
  13. 13. Prognosis Sigurdsson et al (1996) found a mortality rate of 43% in 102 patients with erythroderma , although only 18% of these deaths occurred as a direct result of the patient’s erythroderma. Drug induced disease carries a much better prognosis than that caused by malignancy. Chronic conditions like eczema and psoriasis could lead to a relapsing remitting course.
  14. 14. Conclusion A secondary process occurring as a result of ezcema, psoriasis and lymphoma. Of sudden onset, exfoliative, erythematous and oedematous. Serious complications can arise, which can be life threatening. Management involves close inpatient monitoring and initially topical steroids.
  15. 15. References Gawkrodger, D.J. (2004) Dermatology – An illustrated colour text. 3rd Ed. Churchill Livingstone Harrison, A.L. & Duvic, M. (2004) Diagnosis and Treatment of Sézary Syndrome: The Internet Journal of Dermatology, (5)2. Kassay, E., Saringer, A., Torok, E. & Szalai, Z. (2001) Infantile Psoriasis: A short clinical study. Acta Dermatovenerologica 10(2). Rothe, M.J., Bernstein, M.L. & Grant-Kels, J.M. (2005) Life Threatening Erythroderma: Diagnosing and treating the “red man.” Clinics in Dermatology 23, 206-217. Sigurdsson, V., Toonstra, J., Hezemans-Boer, M. & van Vloten, W.A. (1996) Erythroderma. A clinical and follow-up study of 102 patients, with special emphasis on survival. Journal of the American Academy of Dermatology 35(1), 53-7.